Malaria Global Clinical Trials Review, H2, 2011
GlobalData
September 12, 2011 112 Pages - SKU: GBDT6738753
|
|
Malaria Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, H2, 2011 provides data on the Malaria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malaria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malaria. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Hyperparathyroidism Therapeutics - Introduction
- 2.1 Disease Overview
- 2.2 Epidemiology
- 2.3 Etiology and Pathophysiology
- 2.4 Signs and Symptoms
- 2.5 Diagnosis
- 2.6 Treatment and Management Options
- 2.6.1 Primary Hyperparathyroidism
- 2.6.2 Secondary Hyperparathyroidism
- 2.7 GlobalData Pipeline Report Guidance
- 3 Hyperparathyroidism Therapeutics - Market Characterization
- 3.1 Hyperparathyroidism Therapeutics Market Size (2005-2010) - Global
- 3.2 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - Global
- 3.3 Hyperparathyroidism Therapeutics Market Size (2005-2010) - The US
- 3.4 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - The US
- 3.5 Hyperparathyroidism Therapeutics Market Size (2005-2010) - France
- 3.6 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - France
- 3.7 Hyperparathyroidism Therapeutics Market Size (2005-2010) - Germany
- 3.8 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - Germany
- 3.9 Hyperparathyroidism Therapeutics Market Size (2005-2010) - Italy
- 3.10 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - Italy
- 3.11 Hyperparathyroidism Therapeutics Market Size (2005-2010) - Spain
- 3.12 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - Spain
- 3.13 Hyperparathyroidism Therapeutics Market Size (2005-2010) - The UK
- 3.14 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - The UK
- 3.15 Hyperparathyroidism Therapeutics Market Size (2005-2010) - Japan
- 3.16 Hyperparathyroidism Therapeutics Market Forecast (2010-2017) - Japan
- 3.17 Drivers and Barriers for the Hyperparathyroidism Therapeutics Market
- 3.17.1 Drivers for the Hyperparathyroidism Therapeutics Market
- 3.17.2 Barriers for the Hyperparathyroidism Therapeutics Market
- 3.18 Opportunity and Unmet Need
- 3.19 Key Takeaway
- 4 Hyperparathyroidism Therapeutics - Competitive Assessment
- 4.1 Overview
- 4.2 Strategic Competitor Assessment
- 4.3 Product Profile for the Major Marketed Products in the Hyperparathyroidism Therapeutics Market
- 4.3.1 Sensipar (cinacalcet)
- 4.3.2 Zemplar (paricalcitol)
- 4.3.3 Hectorol (doxercalciferol)
- 4.4 Key Takeaway
- 5 Hyperparathyroidism Therapeutics - Pipeline Assessment
- 5.1 Overview
- 5.2 Strategic Pipeline Assessment
- 5.3 Hyperparathyroidism Therapeutics - Pipeline Analysis by Clinical Phase of Development
- 5.3.1 Hyperparathyroidism Therapeutics - Phase II Clinical Pipeline
- 5.3.2 Hyperparathyroidism Therapeutics - Phase I Pipeline
- 5.4 Hyperparathyroidism Therapeutics - Pipeline by Mechanism of Action
- 5.5 Technology Trends Analytical Framework
- 5.6 Hyperparathyroidism Therapeutics - Most Promising Drugs in Clinical Development
- 5.7 Most Promising Drug Profiles
- 5.7.1 KAI-4169
- 5.7.2 CTA018
- 5.8 Key Takeaway
- 6 Hyperparathyroidism Therapeutics - Clinical Trials Mapping
- 6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
- 6.2 Clinical Trials by Phase of Clinical Development
- 6.3 Clinical Trials by Trial Status
- 6.4 Clinical Trials by Sponsors
- 6.5 Brief Profiles of Companies Participating in Clinical Trials
- 7 Hyperparathyroidism Therapeutics - Strategic Assessment
- 7.1 Key Events Affecting the Future Market
- 7.2 Future Market Competition Scenario
- 8 Hyperparathyroidism Therapeutics - Future Players
- 8.1 Introduction
- 8.2 Company Profiles
- 8.2.1 Cytochroma Inc.
- 8.2.2 KAI Pharmaceuticals Inc.
- 8.2.3 LEO Pharma A/S
- 8.2.4 Abbott Laboratories
- 8.3 Key Takeaway
- 9 Hyperparathyroidism Therapeutics - Licensing & Partnership Deals
- 10 Hyperparathyroidism Therapeutics - Appendix
- 10.1 Market Definitions
- 10.2 Abbreviations
- 10.3 Methodology
- 10.3.1 Coverage
- 10.3.2 Secondary Research
- 10.3.3 Forecasting
- 10.3.4 Primary Research
- 10.3.5 Expert Panel Validation
- 10.4 Contact Us
- 10.5 Disclaimer
- 10.6 Bibliography
- List of Tables
- Malaria Therapeutics Market, Global, Clinical Trials by Zone, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011*
- Malaria Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
- Malaria Therapeutics Clinical Trials, North America, Top Countries, 2011*
- Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011*
- Malaria Therapeutics Clinical Trials, Central and South America, Top Countries, 2011*
- Malaria Therapeutics Clinical Trials, BRIC Countries, 2011*
- Malaria Therapeutics Clinical Trials, G7 Countries, 2011*
- Malaria Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
- Malaria Therapeutics Clinical Trials, E7 Countries, 2011*
- Malaria Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials by Phase, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
- Malaria Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Malaria Therapeutics Market, Global, Suspended Clinical Trials, 2011*
- Malaria Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*
- Malaria Therapeutics Market, Global, Terminated Clinical Trials, 2011*
- Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Malaria Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by IPCA Laboratories Limited, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by EPICENTRE Biotechnologies, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Ranbaxy Laboratories Limited, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Dafra Pharma International Ltd., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanaria Inc., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by PROTO PHARMA PVT. LTD., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by CPR Pharma Services Pty Ltd, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Wanxing Bio-Pharmaceutical Co. Ltd., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Mepha Ltd., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Jomaa Pharma GmbH, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Treague Ltd, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Holland B.V, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Lincoln Pharmaceuticals Ltd, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Immtech Pharmaceuticals, Inc., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal DSM N.V., 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Gates Malaria Partnership, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicines for Malaria Venture (MMV), 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Tropical Medicine, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Drugs for Neglected Diseases initiative, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by African Malaria Network Trust, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital Albert Schweitzer, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by DBL - Centre for Health Research and Development, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherche pour le Developpement, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Liverpool School of Tropical Medicine, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Makerere University, 2011*
- Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2011*
- List of Figures
- Malaria Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
- Malaria Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
- Malaria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
- Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011*
- Malaria Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011*
- Malaria Therapeutics Clinical Trials, BRIC Countries (%), 2011*
- Malaria Therapeutics Clinical Trials, G7 Countries (%), 2011*
- Malaria Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
- Malaria Therapeutics Clinical Trials, E7 Countries (%), 2011*
- Malaria Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
- Malaria Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
- Malaria Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Malaria Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- GlobalData Methodology
Share this report
Other tasks Related Markets Infectious Diseases Reports- Global Infectious Disease Treatment Market 2011-2014
- World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
- Global Infectious Disease Market Outlook: Facilities, Test Volume, and Sales Forecasts by Country
- Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast
- Smallpox Global Clinical Trials Review, H2, 2011
Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
